Ernesto Ayala

3.8k total citations
140 papers, 1.5k citations indexed

About

Ernesto Ayala is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ernesto Ayala has authored 140 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 42 papers in Pathology and Forensic Medicine and 40 papers in Oncology. Recurrent topics in Ernesto Ayala's work include Hematopoietic Stem Cell Transplantation (44 papers), Lymphoma Diagnosis and Treatment (41 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Ernesto Ayala is often cited by papers focused on Hematopoietic Stem Cell Transplantation (44 papers), Lymphoma Diagnosis and Treatment (41 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Ernesto Ayala collaborates with scholars based in United States, Colombia and Lebanon. Ernesto Ayala's co-authors include Mohamed A. Kharfan‐Dabaja, Claudio Anasetti, Teresa Field, Lia Perez, Hugo F. Fernández, Janelle Perkins, Melissa Alsina, Marcie Tomblyn, William E. Janssen and Ambuj Kumar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ernesto Ayala

125 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ernesto Ayala

Since Specialization

Citations

This map shows the geographic impact of Ernesto Ayala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto Ayala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto Ayala more than expected).

Fields of papers citing papers by Ernesto Ayala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto Ayala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto Ayala. The network helps show where Ernesto Ayala may publish in the future.

Co-authorship network of co-authors of Ernesto Ayala

This figure shows the co-authorship network connecting the top 25 collaborators of Ernesto Ayala. A scholar is included among the top collaborators of Ernesto Ayala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernesto Ayala. Ernesto Ayala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis 2023 ·Transplantation and Cellular Therapy ·Anmol Baranwal, (unknown), Khaled Ali, Mohamed A. Kharfan‐Dabaja, Ernesto Ayala, James M. Foran, Hemant S. Murthy, Talha Badar, Madiha Iqbal, Jeanne Palmer, (unknown), Urshila Durani, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mark R. Litzow, William J. Hogan, Hassan B. Alkhateeb	1
2	Detectable Somatic Variants Using Next Generation Sequencing (NGS) Post Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Predict for High Relapse Risk in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) 2023 ·Blood ·(unknown), Liuyan Jiang, Zhuo Li, Hemant S. Murthy, James M. Foran, Vivek Roy, Ernesto Ayala, Mohamed A. Kharfan‐Dabaja, Madiha Iqbal	0
3	Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience 2022 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Muhamad Alhaj Moustafa, Liuyan Jiang, Madiha Iqbal, Karan Seegobin, (unknown), Ernesto Ayala, (unknown), Allison Rosenthal, Jonas Paludo, Ivana N. Micallef, Patrick B. Johnston, David J. Inwards, Thomas M. Habermann, Mohamed A. Kharfan‐Dabaja, Thomas E. Witzig, Grzegorz S. Nowakowski, Han W. Tun	2
4	Impact of Rituximab and Corticosteroids on Late Cytopenias Post-Chimeric Antigen Receptor T Cell Therapy 2022 ·Transplantation and Cellular Therapy ·Madiha Iqbal, Radhika Bansal, (unknown), (unknown), Allison Rosenthal, Muhamad Alhaj Moustafa, Zhuo Li, (unknown), Razan Mohty, Hemant S. Murthy, Ernesto Ayala, Han W. Tun, Javier Muñoz, Januario E. Castro, Yi Lin, Mohamed A. Kharfan‐Dabaja	5
5	Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma 2021 ·Clinical Lymphoma Myeloma & Leukemia ·Madiha Iqbal, (unknown), Jonas Paludo, Allison Rosenthal, Zhuo Li, (unknown), Muhamad Alhaj Moustafa, David J. Inwards, Luis F. Porrata, Ivana N. Micallef, José C. Villasboas, Patrick B. Johnston, Stephen M. Ansell, Craig B. Reeder, Hemant S. Murthy, Vivek Roy, James M. Foran, Han W. Tun, Mohamed A. Kharfan‐Dabaja, Ernesto Ayala	2
6	A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention 2021 ·Blood Advances ·Lia Perez, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, Farhad Khimani, Brian C. Betts, Asmita Mishra, Ernesto Ayala, Frederick L. Locke, (unknown), Michael L. Nieder, Joseph Pidala, (unknown), John J. Powers, Eva Sahakian, Ram Thapa, Xuefeng Wang, Claudio Anasetti	9
7	Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience 2020 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Liuyan Jiang, (unknown), Ernesto Ayala, David M. Menke, Bradford S. Hoppe, Mohamed A. Kharfan‐Dabaja, Han W. Tun, Muhamad Alhaj Moustafa	8
8	Systemic ALK‐positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness 2020 ·SHILAP Revista de lepidopterología ·Karan Seegobin, Muhamad Alhaj Moustafa, (unknown), (unknown), (unknown), Mohamed A. Kharfan‐Dabaja, Ernesto Ayala, Vivek Gupta, Han W. Tun, Liuyan Jiang	2
9	Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome 2020 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Tea Reljic, (unknown), Ernesto Ayala, Julio C. Chávez, Asher Chanan‐Khan, Javier Pinilla‐Ibarz, Ambuj Kumar, Mohamed A. Kharfan‐Dabaja	16
10	C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel ☆ 2020 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Zaid Abdel Rahman, Hollie Saunders, (unknown), (unknown), Allison Rosenthal, Ernesto Ayala, Han W. Tun, Hemant S. Murthy, Vivek Roy, James M. Foran, Januario E. Castro, Pramod Guru, Mohamed A. Kharfan‐Dabaja	4
11	Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis 2017 ·Biology of Blood and Marrow Transplantation ·Mehdi Hamadani, Abraham S. Kanate, Alyssa DiGilio, Kwang Woo Ahn, Sonali M. Smith, Jong Wook Lee, Ernesto Ayala, Nelson J. Chao, Parameswaran Hari, Javier Bolaños‐Meade, Ronald E. Gress, (unknown), Yi‐Bin Chen, Umar Farooq, Gary J. Schiller, Jean A. Yared, Anna Sureda, Timothy S. Fenske, Horatiu Olteanu	22
12	Current state of hematopoietic cell transplantation in CLL as smart therapies emerge 2016 ·Best Practice & Research Clinical Haematology ·Mohamed A. Kharfan‐Dabaja, (unknown), Farrukh T. Awan, Mehdi Hamadani, Ernesto Ayala	4
13	Embarazo molar de 25 semanas con feto vivo: Reporte de autopsia 2016 ·Revista chilena de obstetricia y ginecología ·(unknown), (unknown), (unknown), Ernesto Ayala	1
14	Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient 2016 ·Hematology/Oncology and Stem Cell Therapy ·Ernesto Ayala, (unknown), Taiga Nishihori, Mohamed A. Kharfan‐Dabaja	5
15	Struma ovarii, hallazgos de patología tiroidea en el ovario 2014 ·Revista Cubana de Obstetricia y Ginecología ·(unknown), (unknown), Ernesto Ayala	1
16	Adenocarcinoma oncocítico oxifílico de endometrio: reporte de caso 2013 ·Revista chilena de obstetricia y ginecología ·Ernesto Ayala, (unknown), (unknown), (unknown)	1
17	Carcinoma escamocelular puro primario de vesícula biliar 2012 ·(unknown), (unknown), (unknown), Ernesto Ayala	1
18	Osteopoiquilosis y síndrome de Buschke-Ollendorf: Reporte de caso y revisión de la literatura 2011 ·Salud UIS ·Ernesto Ayala, (unknown)	1
19	Hyalinizing spindle cell tumor with giant rosettes: Case report 2010 ·Salud UIS ·Ernesto Ayala, (unknown), (unknown), (unknown)	1
20	Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL 2003 ·The Journal of Immunology ·(unknown), Mohamed A. Kharfan‐Dabaja, Ernesto Ayala, Despina S. Kolonias, Louise Carlson, (unknown), Uwe Scherf, (unknown), Kelvin P. Lee	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact